IMPACT OF MANUFACTURER COMPETITION ON PRESCRIPTION DRUG PRICE INFLATION IN THE UNITED STATES

被引:0
|
作者
Hernandez, I [1 ]
Good, C. B. [2 ]
Gellad, W. F. [3 ]
Parekh, N. [2 ]
He, M. [1 ]
Shrank, W. H. [2 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] UPMC Insurance Serv Div, Pittsburgh, PA USA
[3] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA
关键词
D O I
10.1016/j.jval.2018.09.928
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP32
引用
收藏
页码:S156 / S156
页数:1
相关论文
共 50 条
  • [41] Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States
    Puac-Polanco, Victor
    Chihuri, Stanford
    Fink, David S.
    Cerda, Magdalena
    Keyes, Katherine M.
    Li, Guohua
    EPIDEMIOLOGIC REVIEWS, 2020, 42 (01) : 134 - 153
  • [42] Relative price variability, inflation rate uncertainty, and postwar investment of the United States
    Glezakos, C
    Nugent, JB
    JOURNAL OF POST KEYNESIAN ECONOMICS, 1996, 19 (02) : 181 - 194
  • [44] Inflation, price competition, and consumer search technology
    Watanabe, Makoto
    JOURNAL OF ECONOMIC DYNAMICS & CONTROL, 2008, 32 (12): : 3780 - 3806
  • [45] THE IMPACT OF INFLATION ON THE REAL INCOME OF UNITED-STATES FARMERS
    STARLEAF, DR
    MEYERS, WH
    WOMACK, AW
    AMERICAN JOURNAL OF AGRICULTURAL ECONOMICS, 1985, 67 (02) : 384 - 389
  • [46] NEGOTIATED ACQUISITIONS - THE IMPACT OF COMPETITION IN THE UNITED-STATES
    HERZEL, L
    SHEPRO, RW
    BUSINESS LAWYER, 1989, 44 (02): : 301 - 322
  • [47] Competition: An antidote to the high price of prescription drugs
    Stein, P
    Valery, E
    HEALTH AFFAIRS, 2004, 23 (04) : 151 - 158
  • [48] Some difficulties of the manufacturer in the United States
    Braubach, C
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY-US, 1922, 14 : 461 - 461
  • [49] PRICE INFLATION AND ITS IMPACT
    PURCELL, JC
    ATLANTA ECONOMIC REVIEW, 1970, 20 (01): : 22 - 26
  • [50] Comparison of Prescription Drug Costs in the United States and the United Kingdom, Part 3: Methylphenidate
    Jick, Hershel
    Wilson, Andrew
    Wiggins, Peter
    Chamberlin, Douglas P.
    PHARMACOTHERAPY, 2012, 32 (11): : 970 - 973